PURE Bioscience, Inc. (PURE)
USD 0.07
(14.75%)
USD 0.07
(14.75%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 1.96 Million | 1.87 Million | 1.85 Million | 3.92 Million | 6.91 Million | 1.9 Million |
| Cost of Revenue | 811 Thousand | 906 Thousand | 853 Thousand | 1.85 Million | 2.89 Million | 728 Thousand |
| Gross Profit | 1.15 Million | 971 Thousand | 1 Million | 2.07 Million | 4.02 Million | 1.18 Million |
| Operating Expenses | 4.28 Million | 4.59 Million | 4.42 Million | 4.38 Million | 4.01 Million | 6.77 Million |
| Selling, General and Administrative Expenses | 3.98 Million | 4.3 Million | 4.1 Million | 4.04 Million | 3.69 Million | 6.41 Million |
| Research and Development Expenses | 302 Thousand | 297 Thousand | 319 Thousand | 339 Thousand | 322 Thousand | 354 Thousand |
| Other Expenses | - | -4000.00 | - | -4000.00 | 5000.00 | 1000.00 |
| Cost and Expenses | 5.09 Million | 5.5 Million | 5.27 Million | 6.23 Million | 6.91 Million | 7.49 Million |
| Operating Income | -3.13 Million | -3.94 Million | -3.42 Million | -2.31 Million | 9000.00 | -5.58 Million |
| Interest Expense | 155 Thousand | 14 Thousand | 6000.00 | 4000.00 | 5000.00 | 6000.00 |
| Income Tax Expense | - | 10 Thousand | 6000.00 | -68.55 Thousand | 10 Thousand | 7000.00 |
| Earnings before Tax | -3.35 Million | -3.96 Million | -3.49 Million | -2.31 Million | 4000.00 | -6.55 Million |
| Net Income | -3.35 Million | -3.96 Million | -3.49 Million | -2.31 Million | -6000.00 | -6.56 Million |
| Earnings Per Share Basic | -0.03 | -0.04 | -0.04 | -0.03 | -0.00 | -0.09 |
| Earnings Per Share Diluted | -0.03 | -0.04 | -0.04 | -0.03 | -0.00 | -0.09 |
| Weighted Average Shares Outstanding | 111.85 Million | 111.4 Million | 88.83 Million | 87.17 Million | 82.2 Million | 72.88 Million |
| Weighted Average Shares Outstanding (Diluted) | 111.85 Million | 111.4 Million | 88.83 Million | 87.17 Million | 84.61 Million | 72.88 Million |
| Gross Margin | 0.59 | 0.52 | 0.54 | 0.53 | 0.58 | 0.62 |
| EBIT Margin | -1.55 | -1.87 | -1.73 | -0.55 | 0.03 | -2.80 |
| Profit Margin | -1.71 | -2.11 | -1.89 | -0.59 | -0.00 | -3.44 |
| EBITDA | -3.04 Million | -3.83 Million | -3.27 Million | -2.14 Million | 201 Thousand | -6.3 Million |
| Earnings Before Tax Margin | -1.60 | -2.10 | -1.85 | -0.59 | 0.00 | -2.93 |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 474 Thousand | 441 Thousand | 326 Thousand | 722 Thousand | 1.87 Million | 602 Thousand |
| Cost of Revenue | 199 Thousand | 183 Thousand | 149 Thousand | 280 Thousand | 906 Thousand | 281 Thousand |
| Gross Profit | 275 Thousand | 258 Thousand | 177 Thousand | 442 Thousand | 971 Thousand | 321 Thousand |
| Operating Expenses | 914 Thousand | 1.07 Million | 1.14 Million | 1.15 Million | 4.59 Million | 1.03 Million |
| Selling, General and Administrative Expenses | 845 Thousand | 998 Thousand | 1.06 Million | 1.07 Million | - | 960 Thousand |
| Research and Development Expenses | 69 Thousand | 77 Thousand | 76 Thousand | 80 Thousand | - | 70 Thousand |
| Other Expenses | - | 1000.00 | - | - | -4000.00 | 4000.00 |
| Cost and Expenses | 1.11 Million | 1.25 Million | 1.29 Million | 1.43 Million | 5.5 Million | 1.31 Million |
| Operating Income | -699 Thousand | -817 Thousand | -964 Thousand | -711 Thousand | -3.94 Million | -1.02 Million |
| Interest Expense | 52 Thousand | 41 Thousand | 38 Thousand | 24 Thousand | 14 Thousand | 8000.00 |
| Income Tax Expense | -65 Thousand | - | - | -6276.00 | 10 Thousand | 8000.00 |
| Earnings before Tax | -756 Thousand | -857 Thousand | -1 Million | -735 Thousand | -3.96 Million | -1.03 Million |
| Net Income | -756 Thousand | -857 Thousand | -1 Million | -735 Thousand | -3.96 Million | -1.03 Million |
| Earnings Per Share Basic | -0.01 | -0.01 | -0.01 | -0.01 | - | -0.01 |
| Earnings Per Share Diluted | -0.01 | -0.01 | -0.01 | -0.01 | - | -0.01 |
| Weighted Average Shares Outstanding | 111.85 Million | 111.85 Million | 111.85 Million | 111.85 Million | 111.4 Million | 111.54 Million |
| Weighted Average Shares Outstanding (Diluted) | 111.85 Million | 111.85 Million | 111.85 Million | 111.85 Million | 111.4 Million | 111.54 Million |
| Gross Margin | 0.58 | 0.59 | 0.54 | 0.61 | 0.52 | 0.53 |
| EBIT Margin | -1.41 | -1.77 | -2.84 | -0.93 | - | -1.15 |
| Profit Margin | -1.59 | -1.94 | -3.07 | -1.02 | -2.11 | -1.71 |
| EBITDA | -666 Thousand | -781 Thousand | -927 Thousand | -674 Thousand | - | -694 Thousand |
| Earnings Before Tax Margin | -1.47 | -1.85 | -2.96 | -0.98 | -2.10 | -1.70 |
8427
CGRA3
300036
OHB
ALEX
SVED-B